NYMOX PHARMACEUTICAL CORPORATION Trade And Other Current Payables
NYMOX PHARMACEUTICAL CORPORATION (NYMXF) had Trade And Other Current Payables of $4.14 million as of 2024-12-31, per its 20-F filed 2025-06-03.
Financial Statements › Notes
ifrs-full:TradeAndOtherCurrentPayables · last filed 2025-06-03
- 2024-12-31: Trade And Other Current Payables $4.14M.
- 2023-12-31: Trade And Other Current Payables $3.05M.
- 2022-12-31: Trade And Other Current Payables $1.93M.
- 2021-12-31: Trade And Other Current Payables $1.56M.
| Period end | Trade And Other Current Payables |
|---|---|
| 2024-12-31 | $4.14M 20-F · filed 2025-06-03 |
| 2023-12-31 | $3.05M 20-F · filed 2025-06-03 |
| 2022-12-31 | $1.93M 20-F · filed 2024-08-29 |
| 2021-12-31 | $1.56M 20-F · filed 2023-05-02 |
| 2021-09-30 | $1.82M 6-K · filed 2021-11-12 |
| 2021-06-30 | $1.65M 6-K · filed 2021-08-13 |
| 2021-03-31 | $1.10M 6-K · filed 2021-05-14 |
| 2020-12-31 | $1.77M 20-F · filed 2023-05-02 |
| 2020-09-30 | $1.80M 6-K · filed 2020-11-13 |
| 2020-06-30 | $1.96M 6-K · filed 2020-08-14 |
| 2020-03-31 | $1.71M 6-K · filed 2020-05-14 |
| 2019-12-31 | $1.89M 20-F · filed 2022-03-30 |
| 2019-09-30 | $1.60M 6-K · filed 2019-11-13 |
| 2019-06-30 | $1.67M 6-K · filed 2019-08-14 |
| 2019-03-31 | $1.36M 6-K · filed 2019-05-15 |
| 2018-12-31 | $1.07M 20-F · filed 2021-03-29 |
| 2018-09-30 | $849.00K 6-K · filed 2018-11-13 |
| 2018-06-30 | $1.61M 6-K · filed 2018-08-13 |
| 2018-03-31 | $2.00M 6-K · filed 2018-05-15 |
| 2017-12-31 | $2.23M 20-F · filed 2020-03-30 |
| 2016-12-31 | $1.37M 20-F · filed 2019-03-29 |
| 2015-12-31 | $2.25M 20-F · filed 2018-03-30 |